SCHEMBL4934294

SCHEMBL4934294

CC(=O)Oc1c(Br)cc(C(N)=O)cc1Br

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.59
HTT P42858 2/20 0.59
APOBEC3A P31941 1/20 0.59
APOBEC3G Q9HC16 1/20 0.59
NCOA1 Q15788 1/20 0.51
NCOA3 Q9Y6Q9 1/20 0.51
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
ALDH1A1 P00352 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
TPMT P51580 1/20 0.40
PARP1 P09874 1/20 0.37
PREP P48147 1/20 0.37
TOP1 P11387 1/20 0.37
CA2 P00918 1/20 0.36
KLK1 P06870 1/20 0.36
LMNA P02545 1/20 0.36
CHEK2 O96017 1/20 0.35
BACE1 P56817 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18196776 0.90 TSHR (0.61) TSHRHTTAPOBEC3AAPOBEC3GNCOA1
SCHEMBL9863397 0.84 TPMT (0.42) TSHRHTTAPOBEC3AAPOBEC3GMEN1
SCHEMBL18281058 0.82 TPMT (0.58) TSHRHTTAPOBEC3AAPOBEC3GMEN1
SCHEMBL18289199 0.81 TPMT (0.40) TSHRHTTAPOBEC3AAPOBEC3GNCOA1
SCHEMBL6936490 0.79 PREP (0.46) HTTMEN1KMT2AALDH1A1TPMT
SCHEMBL4647729 0.79 HSD17B10 (0.50) TSHRHTTMEN1KMT2APREP
SCHEMBL9313940 0.78 TOP1 (0.57) TSHRHTTAPOBEC3AAPOBEC3GNCOA1
SCHEMBL13864993 0.78 BACE1 (0.50) MEN1KMT2ASMN1; SMN2TPMTPREP
SCHEMBL14430071 0.78 KDM4E (0.44) HTTMEN1KMT2AALDH1A1PREP
SCHEMBL7827341 0.78 PREP (0.48) HTTMEN1KMT2ATPMTPREP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed
EP-1732533-A1 THYROID RECEPTOR AGONISTS KARO BIO AB (SE) 2006-12-20 EP disclosed
EP-1732532-A1 NOVEL PHARMACEUTICAL COMPOSITIONS COMPRISING AGONISTS OF THE THYROID RECEPTOR KARO BIO AB (SE) 2006-12-20 EP disclosed
WO-2005092317-A1 THYROID RECEPTOR AGONISTS KARO BIO AB (SE) 2005-10-06 WO disclosed
WO-2005092316-A1 NOVEL PHARMACEUTICAL COMPOSITIONS COMPRISING AGONISTS OF THE THYROID RECEPTOR KARO BIO AB (SE) 2005-10-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA TSHR 1/4885HTT 2290/4885APOBEC3A 3585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.